Hyaluronic Acid in Wound Management: An Update on Formulations, Mechanisms, and Clinical Applications
International Journal of Wound Research · 2025
DOI: 10.64115/ijwr-2025-10 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Wound Research, 2025. Verfasst von Biagio Nicolosi und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Themen: Wundversorgung
Abstract (Originalsprache)
Introduction
HA underpins hydration, immune modulation, and matrix remodeling in wound healing. Its effects vary by molecular weight and formulation, with direct implications for clinical use. This update aims to analyzed and discuss the current knowledge on HA, with the objective of outlining its mechanisms of action and exploring the clinical implications of the various formulations used in wound care.
Methods
This update integrates key contributions (2000–2024) from PubMed, Scopus, and authoritative wound-care texts on the cutaneous use of HA in adult and pediatric patients. Evidence was organized to describe mechanisms, formulation characteristics (HA-only, HA+Ag, HA+AA, HYAFF scaffolds, injectable HA+6AA), and practice integration across acute and chronic wounds. No systematic review procedures were applied.
Results
High-molecular-weight HA shows protective and anti-inflammatory actions; low- molecular-weight HA promotes angiogenesis and immune activation. Clinically, HA-only topicals aid hydration and epithelialization; HA+Ag addresses bioburden; HA+AA supports stalled/ischemic beds; scaffolded HYAFF provides structure and sustained release for deep/exuding wounds; injectable HA+6AA augments remodeling in complex cases. A TIMERS-aligned framework supports step-up/step-down use and escalation when progression thresholds are unmet.
Discussion
HA is a formulation-dependent therapeutic that benefits wound outcomes when matched to phenotype and phase. Heterogeneity of products and outcomes limits cross-study comparability; head-to-head trials and standardized endpoints are priorities to refine indications across hospital and community pathways.
Zitieren
APA
Nicolosi, B., Kruszewska, K., & Gonçalves, V. G. V. (2025). Hyaluronic Acid in Wound Management: An Update on Formulations, Mechanisms, and Clinical Applications. International Journal of Wound Research. https://doi.org/10.64115/ijwr-2025-10
Vancouver
Nicolosi B, Kruszewska K, Gonçalves VGV. Hyaluronic Acid in Wound Management: An Update on Formulations, Mechanisms, and Clinical Applications. International Journal of Wound Research. 2025. doi:10.64115/ijwr-2025-10
BibTeX
@article{Nicolosi2025,
author = {Nicolosi, Biagio and Kruszewska, Karolina and Gonçalves, Viviana Gonçalves Viviana},
title = {Hyaluronic Acid in Wound Management: An Update on Formulations, Mechanisms, and Clinical Applications},
journal = {International Journal of Wound Research},
year = {2025},
doi = {10.64115/ijwr-2025-10}
}
EUVIMED